DevS, a heme-containing two-component oxygen sensor of Mycobacterium tuberculosis

被引:70
作者
Ioanoviciu, Alexandra
Yukl, Erik T.
Moenne-Loccoz, Pierre
de Montellano, Paul R. Ortiz
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA
关键词
D O I
10.1021/bi602422p
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mycobacterium tuberculosis can exist in the actively growing state of the overt disease or in a latent quiescent state that can be induced, among other things, by anaerobiosis. Eradication of the latent state is particularly difficult with the available drugs and requires prolonged treatment. DevS is a member of the DevS-DevR two-component regulatory system that is thought to mediate the cellular response to anaerobiosis. Here we report the cloning, expression, and initial characterization of a truncated version of DevS (DevS642) containing only the N-terminal GAF sensor domain (GAF-A) and of the full-length protein DevS. The DevS truncated construct quantitatively binds heme in a 1:1 stoichiometry, and the complex of the protein with ferrous heme reversibly binds O-2, NO, and CO. UV-vis and resonance Raman spectroscopy of the wild-type protein and the H149A mutant confirm that His149 is the proximal ligand to the heme iron atom. While the heme-CO complex is present as two conformers in the GAF-A domain, a single set of [Fe-C-O] vibrations is observed with the full-length protein, suggesting that interactions between domains within DevS influence the distal pocket environment of the heme in the GAF-A domain.
引用
收藏
页码:4250 / 4260
页数:11
相关论文
共 68 条
[1]   In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv [J].
Ahmad, Z ;
Sharma, S ;
Khuller, GK .
FEMS MICROBIOLOGY LETTERS, 2005, 251 (01) :19-22
[2]   The potential of azole antifungals against latent/persistent tuberculosis [J].
Ahmad, Z ;
Sharma, S ;
Khuller, GK .
FEMS MICROBIOLOGY LETTERS, 2006, 258 (02) :200-203
[3]   Azole antifungals as novel chemotherapeutic agents against murine tuberculosis [J].
Ahmad, Zahoor ;
Sharma, Sadhna ;
Khuller, G. K. .
FEMS MICROBIOLOGY LETTERS, 2006, 261 (02) :181-186
[4]  
ANDERSSON LA, 1989, J BIOL CHEM, V264, P19099
[5]   A chemometric analysis of the resonance Raman spectra of mutant carbonmonoxy-myoglobins reveals the effects of polarity [J].
Anderton, CL ;
Hester, RE ;
Moore, JN .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1338 (01) :107-120
[6]   A RESONANCE RAMAN INVESTIGATION OF MYOGLOBIN AND HEMOGLOBIN [J].
BANGCHAROENPAURPONG, O ;
SCHOMACKER, KT ;
CHAMPION, PM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1984, 106 (19) :5688-5698
[7]   The evolving relation between humans and Mycobacterium tuberculosis [J].
Bloom, BR ;
Small, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :677-678
[8]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[9]   EFFECTS OF NITRIC-OXIDE SYNTHASE INHIBITORS ON MURINE INFECTION WITH MYCOBACTERIUM-TUBERCULOSIS [J].
CHAN, J ;
TANAKA, K ;
CARROLL, D ;
FLYNN, J ;
BLOOM, BR .
INFECTION AND IMMUNITY, 1995, 63 (02) :736-740
[10]   Review: Multidrug-resistant tuberculosis: public health challenges [J].
Coker, RJ .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (01) :25-40